Activation by C5a of endothelial cell caspase 8 and cFLIP

Inflammation Research

Volumn 58, Issue 1, 2009, Pages 30-37

  Albrecht, E A ^a   Sarma, J V ^b   Ward, P A ^b  

^a KENNESAW STATE UNIVERSITY   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Caspase 8; Caspase 8 homologue FLICE; Complement factor 5a (C5a); Cycloheximide (CHX); Inhibitory protein (cFLIP)

Indexed keywords

CASPASE 8; COMPLEMENT COMPONENT C5A; CYCLOHEXIMIDE; FLICE INHIBITORY PROTEIN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1;

ARTICLE; CELL DEATH; CELL VIABILITY; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME ACTIVITY; GENE EXPRESSION; HUMAN; HUMAN CELL;

CASP8 AND FADD-LIKE APOPTOSIS REGULATING PROTEIN; CASPASE 8; CELLS, CULTURED; COMPLEMENT C5A; CYCLOHEXIMIDE; ENDOTHELIAL CELLS; ENZYME ACTIVATION; HUMANS; POLY(ADP-RIBOSE) POLYMERASES;

EID: 58749112341     PISSN: 10233830     EISSN: 1420908X     Source Type: Journal    
DOI: 10.1007/s00011-008-8156-9     Document Type: Article

References (47)

1. Reinhart K, Bayer O, Brunkhorst F, Meisner M. Markers of endothelial damage in organ dysfunction and sepsis. Crit. Care Med. 2002; 30: 302-12.
2. Hack C, Zeerleder S. The endothelium in sepsis: source of and a target for inflammation. Crit. Care Med. 2001; 29: 21-7.
3. Hotchkiss R, Tinsley K, Swanson P, Karl I. Endothelial cell apoptosis in sepsis. Crit. Care Med. 2002; 30: 225-8.
4. Srinivasan SR, Radhakrishnamurthy B, Vijayagopal P, Berenson GS. Proteoglycans, lipoproteins, and atherosclerosis. Adv Exp Med Biol. 1991; 285: 373-81.
5. Bäck M. Inflammatory signaling through leukotriene receptors in atherosclerosis. Curr Atheroscler Rep. 2008; 10(3): 244-51.
6. Kaplanski G, Marin V, Fabrigoule M. Thrombin-activated human endothelial cells supported monocyte adhesion in vitro following expression of intercellular adhesion molecule-1(ICAM-1;CD54) and vascular cell adhesion molecule-1 (VCAM-1; CD106). Blood 1998; 92: 1259-67.
7. Mutunga M, Fulton B, Bullock R, Batchelor A, Gascoigne A, Gillespie J, Baudouin S. Circulating endothelial cells in patients with septic shock. Am J Respir Crit Care Med. 2001; 163: 195-200.
8. Minagar A, Jy W, Jimenez J, Sheremata W, Mauro L, Mao W, et.al. Elevated plasma endothelial microparticles in multiple sclerosis. Neurology 2001; 56: 1319-24.
9. 2-terminal kinase. J Immunol. 2002; 169: 2611-8.
10. Hu X, Ester Y, Harlan J, Wong F, Karsan A. Lipopolysaccharide induces the antiapoptitic molecules A1 and A20 in microvascular endothelial cells. Blood 1998; 92: 2758-65.
11. Pohlman T, Harlan J. Human endothelial cell response to lypopolysaccharide, interleukin-1, and tumor necrosis factor is regulated by protein synthesis. Cell Immunol 1989; 119: 41-9.
12. Harlan J, Harker L, StrikerG, Weaver L. Effects of lipopolysaccharide on human endothelial cells in culture. Thromb Res 1983; 29: 15-26.
13. Zhou M, Simms H, Wang P. Adrenomedullin and adrenomedullin binding protein-1 attenuate vascular endothelial cell apoptosis in sepsis. Ann Surg 2004; 240: 321-30.
14. Rasper D, Vaillancourt J, Hadano S, Houtzager V, Seiden I, Keen S, et al. Cell death attenuation by 'Ursurpin', a mammalian DED-caspase homologue that precludes caspase 8 recruitment an dactivation by the CD-95 (Fas, APO-1) receptor complex. Cell Death Differ 1998; 5: 271-88.
15. Scaffidi C, Schmitz I, Krammer P, Peter M. The role of c-FLIP in modulation of CD95-induced apoptosis. J Biol Chem 1999; 274: 1541-8.
16. Thome M, Schneider P, Hofmann K, Fickenscher H, Meinl E, Neipel F, et al. Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors. Nature 1997; 386: 517-21.
17. L up-regulation. Leukemia 2003; 17: 379-89.
18. Okada Y, Masahiko K, Hisanori M, Yoshinari I, Akihiro Morkawa, Kunio O, Kimura H. Reduced expression of Flice-inhibitory protein (FLIP) and NFκB is associated with death receptor-induced cell death in human aortic endothelial cells (HAECs). Cytokine 2001; 15(2): 66-74.
19. Suhara T, Mano T, Oliveira B, Walsh K. Phosphatidylinositol 3-kinase/Akt signaling controls endothelial cell sensitivity to fas-mediated apoptosis via regulation of FLICE-inhibitory protein (FLIP). Circ Res 2001; 89: 13-9.
20. Reidemann N, Gou R, Neff T, Laudes I, Keller K, Sarma V, et al. Increased C5a receptor expression in sepsis. J. Clin. Invest. 2002; 110: 101-8.
21. Wesche D, Lomas-Neira J, Perl M, Chung C, Ayala A. Leukocyte apoptosis and its significance in sepsis and shock. J Leuk Biol. 2005; 78: 325-37.
22. Perianayagam M, Balakrishnan V, King A, Pereira B, Jaber B. C5a delays apoptosis of human neutrophils by a phosphatidylinositol 3-kinase signaling pathway. Kidney International 2002; 61: 456-63.
23. Guo R, Sun L, Hongwei G, Shi K, Rittirsch D, Sarma V, et al. In vivo regulatin of neutrophil apoptosis by C5a during sepsis. J Leuko Biol 2006; 80: 1575-83.
24. Gasque P, Singhrao S K, Neal JW, Gotze O, Morgan BP. Expression of the receptor for complement C5a (CD88) is up-regulated on reactive astrocytes, microglia, and endothelial cells in the inflamed human central nervous system. Am. J. Pathol. 1997; 150.
25. Foreman KE, Vaporciyan AA, Bonish BK, Jones ML, Johnson K J, Glovsky MM, et al. C5a-induced expression of P-selectin in endothelial cells. J. Clin. Invest. 1994; 94: 1147-55.
26. Monsinjon I, Gasque P, Chan P, Ischenko A, Brady J, Fontaine M. Regulation by complement C3a and C5a anaphylatoxins of cytokine production in human umbilical vein endothelial cells. Faseb J 2003; 17: 1003-14.
27. Albrecht E, Chinnaiyan A, Sooryanarayana V, Kumar-Sinha C, Barrette T, Sarma V, et al. C5a-induced gene expression in human umbilical vein endothelial cells. Am J Pathol 2004; 164: 849-59.
28. Bouchard V, Rouleau M, Poirier G. PARP-1, a determinant of cell survival in response to DNA damage. Exp Hematology 2003; 31: 446-54.
29. Zen H, Karsan A, Stempien-Otero A, Yee E, Tupper J, Li X, et al. NF-κB activation is required for human endothelial survival during exposure to tumor necrosis factor-α but not to interleukin-1β or lipopolysaccharide. J Biol Chem. 1999; 274: 28808-15.
30. Duriez P, Wong F, Dorovini-Zis K, Shahidi R, Karsan A. A1 Functions at the mitochondria to delay endothelial apoptosis in response to tumor necrosis factor. J Biol Chem. 2000; 275: 18099-107.
31. Eissner G, Kohlhuber F, Grell M, Ueffing M, Scheurich P, Hieke A, et al. Critical involvement of transmembrane tumor necrosis factor-α in endothelial programmed cell death mediated by ionizing radiation and bacterial endotoxin. Blood 1995; 86: 4184-93.
32. Miura M, Friedlander R, Yuan J. Tumor necrosis factor-induced apoptosis is mediated by a CrmA-sensitive cell death pathway. Proc. Natl. Acad. Sci. USA 1995; 92: 8318-22.
33. Schindler R, Gelfand J, Dinarello C. Recombinant C5a stimulates transcription rather than translation of interleukin-1(IL-1) and tumor necorsis factor: translational signal provided by lipopolysaccharide of IL-1 itself. Blood 1990; 76: 1631-8.
34. Maelfait J, Beyaert R. Non-apoptotic functions of caspase-8. Biochem Pharmacol. 2008; Aug 6. [Epub ahead of print]
35. Koenig A, Russell JQ, Rodgers WA, Budd RC. Spatial differences in active caspase-8 defines its role in T-cell activation versus cell death. Cell Death Differ. 2008; Jul 11. [Epub ahead of print]
36. Schraufstatter IU, Trieu K, Sikora L, Sriramarao P, DiScipio R. Complement c3a and c5a induce different signal transduction cascades in endothelial cells. J Immunol. 2002; 169(4): 2102-10.
37. Irmler, M., Martinon F, Holler N, Steiner V, Ruegg C, Wajant H, Tschopp J. Caspase-induced inactivation of the anti-apoptotic TRAF1 during Fas ligand-mediated apoptosis. FEBS Lett. 2000; 468: 129-33.
38. Levkau B, Scatena M, Giachelli C.M, Ross R, Raines E. Apoptosis overrides survival signals through a caspase-mediated dominant negative NF-kappa B loop. Nat. Cell Biol. 1999; 1: 227-33.
39. Guo, R.F., Huber-Lang, M., Wang, X., Sarma, V., Padgaonkar, V.A., Craig, R.A., Riedemann, N.C., McClintock, S.D., Hlaing, T., Shi, M.M., and Ward, P.A.: Protective effects of anti-C5a in sepsis-induced thymocyte apoptosis. J Clin Invest. 2000; 106: 1271-80.
40. Flierl, M.A., Rittirsch, D., Chen, A.J., Nadeau, B.A., Day, D.E., Sarma, J.V., Huber-Lang, M.S. and Ward, P.A. The complement anaphylatoxin C5a induces apoptosis in adrenomedullary cells during experimental sepsis. PLoS ONE 2008 On-Line Vol 3/issue 7/e2560.
41. Niederbichler, A.D., Hoesel, L.M., Westfall, M.V., Gao, H., Ipaktchi, K.R., Sun, L., Zetoune, F.S., Su, G.L., Arbabi, S., Sarma, J.V., Wang, S.C., Hemmila, M.R., and Ward, P.A.: An essential role for complement C5a in the pathogenesis of septic cardiac dysfunction. J Experimental Medicine. 2006; 203(1): 53-61.
42. Huber-Lang, M.S., Younkin, E.M., Sarma, J.V., McGuire, S.R., Lu, K.T., Guo, R.F., Padgaonkar, V.A., Curnutte, J.T., Erickson, R., and Ward, P.A.: Complement-induced impairment of innate immunity during sepsis. J Immunol. 2002; 169(6): 3223-31
43. Weche DE, Lomas-Neira JL, Perl M, Chung C-S, and Ayala A. Leukocyte apoptosis and its significance in sepsis and shock. J. Leukoc. Biol. 2005; 78: 325-7.
44. Hoesel, LM, Niederbichler AD, Schaefer J, Ipaktchi KR, Gao H, Rittirsch D, Pianko MJ, Vogt PM, Sarma JV, Su GL, Arbabi S, Westfall MV, Wang Sc, Hemmila MR and Ward PA. C5a-blockade improves burn-induced cardiac dysfunction. J. Immunol. 2007; 178: 7902-10
45. Kay J, Korner A. Effects of cycloheximide on protein and ribonucleic acid synthesis in cultured human lympocytes. Biochem J. 1966; 100: 815-22.
46. Kreuz S, Siegmund D, Scheurich P, Wajant H. NF-κB inducers upregulate cFLIP, a cycloheximide-sensitive inhibitor of death receptor signaling. Mol Cell Biol. 2001; 21: 3964-73.
47. Choi K, Wong F, Harlan J, Chaundhary P, Hood L, Karsan A. Lipopolysaccharide mediates endothelial apoptosis by a FADD-dependent pathway. J Biol Chem. 1998; 273: 20185-8.